Ponatinib in patients with refractory acute myeloid leukaemia: Findings from a phase 1 study

Neil P. Shah, Moshe Talpaz, Michael W.N. Deininger, Michael J. Mauro, Ian W. Flinn, Dale Bixby, Stephanie Lustgarten, Joseph M. Gozgit, Tim Clackson, Christopher D. Turner, Frank G. Haluska, Hagop Kantarjian, Jorge E. Cortes

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)548-552
Number of pages5
JournalBritish Journal of Haematology
Volume162
Issue number4
DOIs
StatePublished - Aug 1 2013
Externally publishedYes

Keywords

  • Acute myeloid leukaemia
  • FLT3 internal tandem duplications
  • FMS-like tyrosine kinase-3
  • Ponatinib
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Hematology

Cite this

Ponatinib in patients with refractory acute myeloid leukaemia : Findings from a phase 1 study. / Shah, Neil P.; Talpaz, Moshe; Deininger, Michael W.N.; Mauro, Michael J.; Flinn, Ian W.; Bixby, Dale; Lustgarten, Stephanie; Gozgit, Joseph M.; Clackson, Tim; Turner, Christopher D.; Haluska, Frank G.; Kantarjian, Hagop; Cortes, Jorge E.

In: British Journal of Haematology, Vol. 162, No. 4, 01.08.2013, p. 548-552.

Research output: Contribution to journalLetter

Shah, NP, Talpaz, M, Deininger, MWN, Mauro, MJ, Flinn, IW, Bixby, D, Lustgarten, S, Gozgit, JM, Clackson, T, Turner, CD, Haluska, FG, Kantarjian, H & Cortes, JE 2013, 'Ponatinib in patients with refractory acute myeloid leukaemia: Findings from a phase 1 study', British Journal of Haematology, vol. 162, no. 4, pp. 548-552. https://doi.org/10.1111/bjh.12382
Shah, Neil P. ; Talpaz, Moshe ; Deininger, Michael W.N. ; Mauro, Michael J. ; Flinn, Ian W. ; Bixby, Dale ; Lustgarten, Stephanie ; Gozgit, Joseph M. ; Clackson, Tim ; Turner, Christopher D. ; Haluska, Frank G. ; Kantarjian, Hagop ; Cortes, Jorge E. / Ponatinib in patients with refractory acute myeloid leukaemia : Findings from a phase 1 study. In: British Journal of Haematology. 2013 ; Vol. 162, No. 4. pp. 548-552.
@article{35a08e649d2c4b42b35ad3208a3c16ed,
title = "Ponatinib in patients with refractory acute myeloid leukaemia: Findings from a phase 1 study",
keywords = "Acute myeloid leukaemia, FLT3 internal tandem duplications, FMS-like tyrosine kinase-3, Ponatinib, Tyrosine kinase inhibitor",
author = "Shah, {Neil P.} and Moshe Talpaz and Deininger, {Michael W.N.} and Mauro, {Michael J.} and Flinn, {Ian W.} and Dale Bixby and Stephanie Lustgarten and Gozgit, {Joseph M.} and Tim Clackson and Turner, {Christopher D.} and Haluska, {Frank G.} and Hagop Kantarjian and Cortes, {Jorge E.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1111/bjh.12382",
language = "English (US)",
volume = "162",
pages = "548--552",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Ponatinib in patients with refractory acute myeloid leukaemia

T2 - Findings from a phase 1 study

AU - Shah, Neil P.

AU - Talpaz, Moshe

AU - Deininger, Michael W.N.

AU - Mauro, Michael J.

AU - Flinn, Ian W.

AU - Bixby, Dale

AU - Lustgarten, Stephanie

AU - Gozgit, Joseph M.

AU - Clackson, Tim

AU - Turner, Christopher D.

AU - Haluska, Frank G.

AU - Kantarjian, Hagop

AU - Cortes, Jorge E.

PY - 2013/8/1

Y1 - 2013/8/1

KW - Acute myeloid leukaemia

KW - FLT3 internal tandem duplications

KW - FMS-like tyrosine kinase-3

KW - Ponatinib

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84880703294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880703294&partnerID=8YFLogxK

U2 - 10.1111/bjh.12382

DO - 10.1111/bjh.12382

M3 - Letter

C2 - 23691988

AN - SCOPUS:84880703294

VL - 162

SP - 548

EP - 552

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -